BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2011400)

  • 1. Rearrangement and overexpression of D11S287E, a candidate oncogene on chromosome 11q13 in benign parathyroid tumors.
    Rosenberg CL; Kim HG; Shows TB; Kronenberg HM; Arnold A
    Oncogene; 1991 Mar; 6(3):449-53. PubMed ID: 2011400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular cloning and chromosomal mapping of DNA rearranged with the parathyroid hormone gene in a parathyroid adenoma.
    Arnold A; Kim HG; Gaz RD; Eddy RL; Fukushima Y; Byers MG; Shows TB; Kronenberg HM
    J Clin Invest; 1989 Jun; 83(6):2034-40. PubMed ID: 2723071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic abnormalities in sporadic parathyroid adenomas.
    Friedman E; Bale AE; Marx SJ; Norton JA; Arnold A; Tu T; Aurbach GD; Spiegel AM
    J Clin Endocrinol Metab; 1990 Aug; 71(2):293-7. PubMed ID: 2199477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel cyclin encoded by a bcl1-linked candidate oncogene.
    Motokura T; Bloom T; Kim HG; Jüppner H; Ruderman JV; Kronenberg HM; Arnold A
    Nature; 1991 Apr; 350(6318):512-5. PubMed ID: 1826542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coding sequence of the overexpressed transcript of the putative oncogene PRAD1/cyclin D1 in two primary human tumors.
    Rosenberg CL; Motokura T; Kronenberg HM; Arnold A
    Oncogene; 1993 Feb; 8(2):519-21. PubMed ID: 8426754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Overexpression of PRAD1 gene in B-cell malignancy with t(11;14)(q13;q32) translocation].
    Iida S; Seto M; Yamamoto K; Ueda R
    Nihon Rinsho; 1992 Jun; 50(6):1374-9. PubMed ID: 1518159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1.
    Lammie GA; Fantl V; Smith R; Schuuring E; Brookes S; Michalides R; Dickson C; Arnold A; Peters G
    Oncogene; 1991 Mar; 6(3):439-44. PubMed ID: 2011398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PRAD1 (cyclin D1): a parathyroid neoplasia gene on 11q13.
    Arnold A; Motokura T; Bloom T; Rosenberg C; Bale A; Kronenberg H; Ruderman J; Brown M; Kim HG
    Henry Ford Hosp Med J; 1992; 40(3-4):177-80. PubMed ID: 1483873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue-specific regulatory regions of the PTH gene localized by novel chromosome 11 rearrangement breakpoints in a parathyroid adenoma.
    Mallya SM; Wu HI; Saria EA; Corrado KR; Arnold A
    J Bone Miner Res; 2010 Dec; 25(12):2606-12. PubMed ID: 20641034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A possible tumor suppressor gene for parathyroid adenomas.
    Iwasaki H
    Int Surg; 1996; 81(1):71-6. PubMed ID: 8803711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal loss of one chromosome 11 in a parathyroid adenoma.
    Arnold A; Kim HG
    J Clin Endocrinol Metab; 1989 Sep; 69(3):496-9. PubMed ID: 2569472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PRAD1/cyclin D1 proto-oncogene: genomic organization, 5' DNA sequence, and sequence of a tumor-specific rearrangement breakpoint.
    Motokura T; Arnold A
    Genes Chromosomes Cancer; 1993 Jun; 7(2):89-95. PubMed ID: 7687458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosome 11 genomic changes in parathyroid adenoma and hyperplasia: array CGH, FISH, and tissue microarrays.
    Yi Y; Nowak NJ; Pacchia AL; Morrison C
    Genes Chromosomes Cancer; 2008 Aug; 47(8):639-48. PubMed ID: 18398822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct target regions for chromosome 1p deletions in parathyroid adenomas and carcinomas.
    Välimäki S; Forsberg L; Farnebo LO; Larsson C
    Int J Oncol; 2002 Oct; 21(4):727-35. PubMed ID: 12239610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cyclin D1/PRAD1 oncogene in human neoplasia.
    Arnold A
    J Investig Med; 1995 Dec; 43(6):543-9. PubMed ID: 8605613
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytogenetic and molecular analyses of multiple endocrine neoplasias of the MEN1 syndrome.
    Pourani J; Kaserer K; Pfragner R
    Int J Oncol; 2002 May; 20(5):971-6. PubMed ID: 11956591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of 11q23 and cyclin D1 overexpression are frequent aberrations in parathyroid adenomas.
    Hemmer S; Wasenius VM; Haglund C; Zhu Y; Knuutila S; Franssila K; Joensuu H
    Am J Pathol; 2001 Apr; 158(4):1355-62. PubMed ID: 11290553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatic mutation of the MEN1 gene in parathyroid tumours.
    Heppner C; Kester MB; Agarwal SK; Debelenko LV; Emmert-Buck MR; Guru SC; Manickam P; Olufemi SE; Skarulis MC; Doppman JL; Alexander RH; Kim YS; Saggar SK; Lubensky IA; Zhuang Z; Liotta LA; Chandrasekharappa SC; Collins FS; Spiegel AM; Burns AL; Marx SJ
    Nat Genet; 1997 Aug; 16(4):375-8. PubMed ID: 9241276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent loss of chromosome arm 1p DNA in parathyroid adenomas.
    Cryns VL; Yi SM; Tahara H; Gaz RD; Arnold A
    Genes Chromosomes Cancer; 1995 May; 13(1):9-17. PubMed ID: 7541648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonality and abnormal parathyroid hormone genes in parathyroid adenomas.
    Arnold A; Staunton CE; Kim HG; Gaz RD; Kronenberg HM
    N Engl J Med; 1988 Mar; 318(11):658-62. PubMed ID: 3344017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.